Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: Correlation and comparison with published Vienna applicator data

Brachytherapy

Volumn 7, Issue 4, 2008, Pages 336-342

  Yaparpalvi, Ravindra ^a   Mutyala, Subhakar ^a   Gorla, Giridhar R ^b   Butler, James ^c   Mah, Dennis ^a   Garg, Madhur K ^a   Kalnicki, Shalom ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Comprehensive Blood and Cancer Center ^*  (United States)

^c Maimonides Cancer Center   (United States)

Author keywords

Bladder; Cervix; ICRU reference dose; Intracavitary interstitial brachytherapy; Rectum; Volumetric dose

Indexed keywords

ADVANCED CANCER; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; HISTOGRAM; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RECTUM; REFERENCE VALUE; TREATMENT PLANNING; UTERINE CERVIX CANCER; VOLUMETRY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 53349146617     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.05.005     Document Type: Article

References (48)

1. International Commission on Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary therapy in gynecology, ICRU Report 38 (1985), ICRU, Bethesda, MD
2. Nag S., Orton C., Young D., et al. The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol 73 (1999) 111-118
3. Potter R., Limbergen E.V., Gerstner N., et al. Survey of the use of ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 58 (2001) 11-18
4. Nag S. Controversies and new developments in gynecologic brachytherapy: Image based intracavitary brachytherapy for cervical carcinoma. Semin Radiat Oncol 16 (2006) 164-167
5. Haie-Meder C., Potter R., Van Limbergen E., et al. Recommendations from gynecological (GYN) GEC ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
6. Lang S., Nulens A., Briot E., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 78 (2006) 185-193
7. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
8. Wolfson A.H. Magnetic resonance imaging and positron-emission tomography imaging in the 21st century as tools for the evaluation and management of patients with invasive cervical carcinoma. Semin Radiat Oncol 16 (2006) 186-191
9. Barillot I., Horiot J.C., Maingon P., et al. Maximum and mean bladder dose defined by ultrasonography. Comparison with the ICRU reference in gynecological brachytherapy. Radiother Oncol 30 (1994) 231-238
10. Kapp K.S., Stueckschweiger G.F., Kapp D.S., et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol 24 (1992) 137-146
11. Kim R.Y., and Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in the cancer of the cervix: Analysis of dose-volume histograms. Brachytherapy 2 (2003) 200-206
12. Ling C.C., Shell M.C., Working K.R., et al. CT-assisted assessment of the bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 13 (1987) 1577-1582
13. Pelloski C.E., Palmer M., Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
14. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 28 (1994) 277-283
15. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 68 (2003) 269-276
16. Datta N.R., Srivastava A., Maria Das K.J., et al. Comparative assessment of doses to tumor, rectum and bladder as evaluated by orthogonal radiographs vs computer Enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 5 (2006) 223-229
17. Kuipers T.J., and Visser A.G. Technical aspects of bladder dosimetry in intracavitary irradiation of cervix carcinoma. Radiother Oncol 7 (1987) 7-12
18. Lahtinen T., Tenhunen M., and Vayrynen M. ICRU reference points and maximum doses of rectum and bladder in intracavitary radiotherapy. Radiother Oncol 28 (1993) 174-176
19. Hunter R., Wong F., Moore C., et al. Bladder base dosage in patients undergoing intracavitary therapy. Radiother Oncol 7 (1986) 189-197
20. Deshpande D., Shrivatsav S., Pradhan A., et al. Dosimetry of intracavitary applications in carcinoma of the cervix: Rectal dose analysis. Radiother Oncol 42 (1997) 163-166
21. Kessaris N., and Nori D. Rectal thermoluminiscent dosimeter measurements using the microselectron high dose rate remote after loader in postoperative intravaginal radiation cases. Int J Radiat Oncol Biol Phys 26 (1993) 341-345
22. Kim R.Y., and Jun Duan S.S. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: Dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel. Brachytherapy 6 (2007) 187-194
23. Fellner C., Potter R., Knocke T.H., et al. Comparison of radiography and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 58 (2001) 53-62
24. Kirisits C., Potter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
25. Nag S., Erickson B., Thomasden B., et al. The American brachytherapy society recommendations for high-dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48 (2000) 201-211
26. Kirisits C., Lang S., Dimopoulos J.C.A., et al. The Vienna Applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 65 (2006) 624-630
27. Dimopoulos J.C.A., Kirisits C., Petric P., et al. The Vienna Applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 66 (2006) 83-90
28. Agrawal P.P., Singhal S.S., Neema J.P., et al. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies. Gynecol Oncol 99 (2005) 169-175
29. Demanes D.J., Rodriguez R.R., Bendre D.D., et al. High dose rate transperineal interstitial brachytherapy for cervical cancer: High pelvic control and low complication rates. Int J Radiat Oncol Biol Phys 45 (1999) 105-112
30. Monk B.J., Krishnansu T., Burger R.A., et al. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer. Gynecol Oncol 67 (1997) 241-247
31. Nag S., Rafael M.M., Alberto E.S., et al. Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina. Gynecol Oncol 70 (1998) 27-32
32. Nath R., Anderson L.L., Luxton G., et al. for the AAPM. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group no. 43. Med Phys 22 (1995) 209-234
33. Steggerda M.J., Moonen L.M.F., Damen E.M.F., et al. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distribution in rectum and bladder. Int J Radiat Oncol Biol Phys 39 (1997) 237-245
34. Van den Bergh F., Meertens H., Moonen L.M.F., et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 47 (1998) 85-90
35. Kirists C., Siebert F.A., Baltas D., et al. Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems. Radiother Oncol 84 (2007) 290-297
36. Pourquier H., Dubois J.B., and Delard R. Cancer of the uterine cervix: Dosimetric guidelines for prevention of late rectal and sigmoid complications as a result of radio therapeutic treatment. Int J Radiat Oncol Biol Phys 8 (1982) 1887-1895
37. Stryker J.A., Bartholomew M., Velkeley D.E., et al. Bladder and rectal complications following radiotherapy for cervical cancer. Gynecol Oncol 29 (1988) 1-11
38. Montana G.S., and Fowler W.C. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 16 (1989) 95-100
39. Chen M.S., Lin F.J., Hong C.H., et al. High-dose rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan. Int J Radiat Oncol Biol Phys 20 (1991) 915-919
40. Ongino I., Kitamura T., Okamoto N., et al. Late rectal complications following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 31 (1995) 725-734
41. Clark B., Souhami L., Roman T.N., et al. The prediction of late rectal complications in patients treated with high dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 38 (1997) 989-993
42. Shin K.H., Huh S.J., Chie E.K., et al. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: In vivo dosimetric analysis. Radiat Med 17 (1999) 289-293
43. Ferrigno R., Santos Novaes P.E.R., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 50 (2001) 1123-1135
44. Katz A., and Eifel P.J. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48 (2000) 1417-1425
45. Chen S.W., Liang J.A., Yeh L.S., et al. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 60 (2004) 663-671
46. Koom W.S., Sohn D.K., Kim J.Y., et al. Computed tomography-based high-dose rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 68 (2007) 1446-1454
47. Potter R., Dimopoulos J., Bachtiary B., et al. 3D Conformal HDR-brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: Clinical experience with 3-year follow-up. Radiother Oncol 79 (2006) 80-86
48. Huang E.Y., Lin H., Hsu H.C., et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 79 (2000) 406-410